Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.08.06.239574v1?rss=1 Authors: Kim, H. K., Kim, H., Lee, M. K., Choi, W. H., Jang, Y., Shin, J. S., Park, J.-Y., Kim, K. H., Han, H. W., Kim, M., Lim, Y. C., Yoo, J. Abstract: Palatine tonsil plays role in the immune system's first line of defense against foreign pathogens. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic since the infection was first reported in China in December 2019. The aim of this study was to establish tonsil epithelial cell-derived organoids and to examine their feasibility as an ex vivo model for SARS-CoV-2 infection. Using an optimized protocol, we achieved 3D tonsil organoid culture from human tonsil tissue that reflects the distinctive characteristics of the tonsil epithelium, such as its cellular composition, histologic properties, and molecular biological features. Notably, we verified that SARS-CoV-2 can infect tonsil organoids with a robust replication efficiency. Furthermore, treatment with remdesivir, an antiviral agent, effectively protected them from viral infection. Therefore, tonsil organoids could be available for investigation of SARS-CoV-2 infection-mediated pathology and for preclinical screening of novel antiviral drug candidates. Copy rights belong to original authors. Visit the link for more info